Cannaisseur Group Inc. SEC filings TCRG

Cannaisseur Group Inc. has 72 filings in SEC EDGAR's recent list, going back to Feb 14, 2022. Its latest annual report, Form 10-K, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 28, 2025 (regulation fd disclosure). The company's fiscal year ends on December 31.

Cannaisseur Group Inc. SEC filings
Form Description Filed Period
NT 10-Q Form nt 10-q Nov 13, 2025 Sep 30, 2025
NT 10-Q Form nt 10-q Aug 15, 2025 Jun 30, 2025
NT 10-Q Form nt 10-q May 16, 2025 Mar 31, 2025
EFFECT Filing Mar 28, 2025 —
D Filing Feb 13, 2025 —
D Filing Feb 13, 2025 —
D Filing Feb 10, 2025 —
NT 10-Q Form nt 10-q Nov 14, 2024 Sep 30, 2024
NT 10-Q Form nt 10-q Aug 14, 2024 Jun 30, 2024
D Filing Aug 9, 2024 —
D Filing Aug 9, 2024 —
D Filing Aug 9, 2024 —
D Filing Aug 9, 2024 —
8-A12G Form 8-a12g Jun 27, 2024 —
NT 10-K Form nt 10-k Apr 1, 2024 Dec 31, 2023
EFFECT Filing Nov 13, 2023 —
CORRESP Letter to the SEC Nov 7, 2023 —
CORRESP Letter to the SEC Nov 1, 2023 —
UPLOAD Letter from the SEC Oct 26, 2023 —
CORRESP Letter to the SEC Oct 12, 2023 —
UPLOAD Letter from the SEC Aug 10, 2023 —
CORRESP Letter to the SEC Jul 18, 2023 —
UPLOAD Letter from the SEC Oct 3, 2022 —
CORRESP Letter to the SEC Sep 19, 2022 —
CORRESP Letter to the SEC Aug 15, 2022 —
UPLOAD Letter from the SEC Mar 18, 2022 —

Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
TCRG (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Atlanta, GA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1879270

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.